Michel Vounatsos
Director/Board Member presso REVVITY, INC.
Patrimonio netto: 15 M $ in data 31/03/2024
Profilo
Michel Vounatsos è nel consiglio di amministrazione di PerkinElmer, Inc. (Stati Uniti), LInstitut de RYthmologie et Modlisation Cardiaque e n-Lorem Foundation e Chief Executive Officer & Director presso Biogen, Inc. Nella sua carriera passata ha occupato la posizione di Presidente-Primary Care & Customer Business Line presso Merck & Co., Inc. Il signor Vounatsos ha conseguito un MBA presso la cole des Hautes tudes Commerciales di Parigi.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOGEN INC.
0.05% | 28/04/2023 | 67 262 ( 0.05% ) | 15 M $ | 31/03/2024 |
REVVITY, INC.
0.01% | 15/05/2023 | 6 486 ( 0.01% ) | 681 030 $ | 31/03/2024 |
ZAI LAB LTD.
0.02% | 30/06/2023 | 183 320 ( 0.02% ) | 302 159 $ | 31/03/2024 |
Posizioni attive di Michel Vounatsos
| Società | Posizione | Inizio |
|---|---|---|
| REVVITY, INC. | Director/Board Member | 01/03/2020 |
| ZAI LAB LIMITED | Director/Board Member | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Chief Executive Officer | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Chief Executive Officer | - |
| L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | - |
| n-Lorem Foundation | Director/Board Member | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Director/Board Member | - |
Precedenti posizioni note di Michel Vounatsos
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Chief Executive Officer | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Formazione di Michel Vounatsos
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
| L’Institut de RYthmologie et Modélisation Cardiaque | |
| n-Lorem Foundation | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |
- Borsa valori
- Insiders
- Michel Vounatsos
